Trials / Sponsors / Salubris Biotherapeutics Inc
Salubris Biotherapeutics Inc
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypert HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction, Group 2 Pulmonary Hypertension | Phase 2 | 2025-12-15 |
| Recruiting | Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer Solid Tumor | Phase 1 / Phase 2 | 2024-10-23 |
| Recruiting | Study of JK07 in Patients With Chronic Heart Failure Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | Phase 2 | 2024-03-28 |
| Withdrawn | Single-Ascending Dose Study of JK07 in Subjects With HFpEF Heart Failure With Preserved Ejection Fraction | Phase 1 | 2022-10-21 |
| Active Not Recruiting | Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer Cancer, Tumor, Solid, Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-10-17 |
| Completed | Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) Heart Failure With Reduced Ejection Fraction | Phase 1 | 2020-09-21 |